Amoxicillin-Clavulanate

C. diff Risk

Medium

Oral Bioavailability

Good (70 to 90%)

Approximate Cost

$

Dosing

15 mg/kg, PO, 2xdaily

Renally cleared, requires dosage adjustment with changes in renal function. Consult a pharmacist for renal dosing.

Use with caution. Use contraindicated in patients with a history of amoxicillin and clavulanate-associated hepatic dysfunction.

For high dose, to keep clavulanic acid dose < 12.5 mg/kg/DAY, 14:1 formulation (90mg/kg/DAY) can be achieved by combining 45mg/kg/DAY of 7:1 formulation & 45mg/kg/DAY of plain amoxicillin.

General Information

Common Usage

Prophylaxis/treatment of bite wounds

Polymicrobial infections of the respiratory tract or abdomen

Drug Monitoring

For prolonged therapy, monitor liver enzymes and function

Adverse Effects

  • Diarrhea (common)

  • Allergy/rash, cytopenias

  • Hepatotoxicity due to clavulinate is usually mild, liver failure is rare

  • EBV related rash (not allergy)

Pharmacology

Antimicrobial class: Aminopenicillin + Beta-lactamase inhibitor

Average serum half life: Adults: ~1 hour. Amoxicillin pharmacokinetics are not affected by clavulanic acid

Biliary Penetration: Good

Route of Elimination: Urine (amoxicillin 50% to 70% unchanged drug; clavulanic acid 25% to 40% unchanged drug)